Friedberg Ezra M's Form 4/A amendment
AmendedPelthos Therapeutics Inc. (PTHS) · filed Mar 12, 2024
- Accession no.
- 0001753926-24-000518
- Filed
- Mar 12, 2024
- Trade date
- Feb 21, 2024
- Filing delay
- 20 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Feb 21, 2024
This filing lists 1 non-derivative transaction. It carries over 4 transactions from the original filing that it did not restate. Open-market purchases total $100.0K. It was filed 20 days after the trade.
This amendment restates part of 0001753926-24-000372 (filed Feb 23, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Friedberg Ezra MCIK 0001679440 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Common Stock | PPurchaseAcquired | +16,667 | $6.00F1 | +$100,002 | 545,721 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001753926-24-000372 (filed Feb 23, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Common Stock | MOption exerciseAcquired | +13,649 | $4.80F2 | +$65,515.2 | 513,727 | Indirect | |
| Feb 21, 2024 | Common Stock | MOption exerciseAcquired | +6,992 | $4.80F3 | +$33,561.6 | 520,719 | Indirect |
Derivative securities (Table II)
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
Represents $65,513.61 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due February 29, 2024, which automatically converted into 13,649 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.
- F3
Represents $33,136.00 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due March 1, 2024, which automatically converted into 6,992 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, including an additional 88 shares of common stock issued as consideration for this senior secured convertible promissory note.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Form 4/A is being filed to include the purchase of 16,667 shares of the Issuer's common stock (the "Common Stock") in the Issuer's initial public offering, in addition to the securities originally reported on the Form 4 filed by the reporting person on February 21, 2024.
Referenced by the price of 1 transaction in Table I.